1. Medtech Insight

Minute Insight: Medtronic Relaunches Harmony Pulmonary Valve Replacement

 
• By Reed Miller

The company pulled Harmony from the market about a year ago following six reports of the capsule at the end of its delivery catheter breaking.

Minute Insight
• Source: Citeline/Alamy

Medtronic is bringing its Harmony transcatheter pulmonary valve (TPV) back to the US market nearly a year after recalling it.

The company pulled Harmony from the market in March 2022, about a year after the US Food and Drug Administration approved it as a treatment for severe pulmonary valve regurgitation in patients with a congenital malformation of the right ventricular outflow tract

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

LSX Europe: Women’s Health Education Is The Key For Unlocking VC Investment

 
• By Natasha Barrow

Flo Health was the first femtech unicorn to be valued at over $1bn. But the company faced 49 investment rejections before reaching that status, Anna Klepchukova, the company’s chief medical officer, told the LSX World Congress Europe. THENA Capital’s Esther Reynal de St Michel Richardot talked through the firm’s gender-smart investment strategy.

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By Marion Webb

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.